[A14-22] Umeclidinium/vilanterol - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 15.10.2014
Project no.:
A14-22
Commission:
Commission awarded on 14.07.2014 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Airways and respiratory system
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A14-45 | Addendum to Commission A14-22 (Umeclidinium/vilanterol) | Commission completed |